Literature DB >> 11891231

Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha ) is required for hepatocyte-specific expression of factor XI.

Takashi Tarumi1, Dmitri V Kravtsov, Mingming Zhao, Scott M Williams, David Gailani.   

Abstract

Factor XI is the zymogen of a plasma protease produced primarily in liver that is required for normal blood coagulation. We cloned approximately 2600 base pairs of the human factor XI gene upstream of exon one, identified transcription start sites, and conducted a functional analysis. Luciferase reporter assays demonstrate that the 381 base pairs upstream of exon one are sufficient for maximum promoter activity in HepG2 hepatocellular carcinoma cells. The removal of 19 base pairs between -381 and -363 results in a nearly complete loss of promoter activity. This region contains the sequence ACTTTG, a motif required for binding of the transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) to the promoters of several genes. Gel mobility shift assays using HepG2 or rat hepatocyte nuclear extract confirm HNF-4alpha binds between bp -375 and -360. Scrambling the ACTTTG motif completely abolishes promoter activity in luciferase assays. The factor XI promoter functions poorly when transfected into HeLa carcinoma cells, and gel mobility shift experiments with HeLa nuclear extracts demonstrate no HNF-4alpha binding to the ACTTTG sequence. When a rat HNF-4alpha expression construct is co-transfected into HeLa cells, factor XI promoter activity is enhanced approximately 10-fold. We conclude that HNF-4alpha is required for hepatocyte-specific expression of factor XI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891231     DOI: 10.1074/jbc.M201886200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

2.  Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression.

Authors:  Yusuke Inoue; Luanne L Peters; Sun Hee Yim; Junko Inoue; Frank J Gonzalez
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

3.  Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene.

Authors:  Minyoung Kong; Younyoung Kim; Chaeyoung Lee
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

4.  Factor XI protein in human pancreas and kidney.

Authors:  Qiufang Cheng; Jeanelle Kantz; Greg Poffenberger; Alvin C Powers; David Gailani
Journal:  Thromb Haemost       Date:  2008-07       Impact factor: 5.249

5.  Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene.

Authors:  Kaoru Inoue; Masahiko Negishi
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

Review 6.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

7.  Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα.

Authors:  Huma Safdar; Ka Lei Cheung; Hans L Vos; Frank J Gonzalez; Pieter H Reitsma; Yusuke Inoue; Bart J M van Vlijmen
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

8.  Regulation of the F11, Klkb1, Cyp4v3 gene cluster in livers of metabolically challenged mice.

Authors:  Huma Safdar; Audrey C A Cleuren; Ka Lei Cheung; Frank J Gonzalez; Hans L Vos; Yusuke Inoue; Pieter H Reitsma; Bart J M van Vlijmen
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

9.  MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha.

Authors:  Salam Salloum-Asfar; Ana B Arroyo; Raúl Teruel-Montoya; Nuria García-Barberá; Vanessa Roldán; Vicente Vicente; Constantino Martínez; Rocío González-Conejero
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.